Treatment-resistant melanoma may be vulnerable to a drug holiday, study finds

http://ift.tt/eA8V8J A new study has uncovered the mechanisms by which treatment-resistant melanoma become vulnerable to cessation of a class of drugs called MAP kinase (MAPK)-targeted inhibitors. By identifying these mechanisms, the scientists discovered that therapeutic benefits for patients could derive from a one-two punch of a drug holiday of MAPK inhibitors followed by a class of drugs called DNA repair inhibitors.

from http://ift.tt/2wE5wNj
via IFTTT